Head to head
CME Group vs S&P Global
Side-by-side on the measures that matter, with a plain-English read. Full detail: CME · SPGI
CME
CME Group
276.01+1.79%
1-year price shape — +10% over the period
Quant Rating C · 38/100
vs
SPGI
S&P Global
405.32+0.30%
1-year price shape — -15% over the period
Quant Rating E · 10/100
CME Group edges it on the scoreable measures. CME Group has the highest Quant Rating (38); CME Group has done best over the past year (+10%); CME Group trades cheapest on trailing earnings.
| CME | SPGI | |
|---|---|---|
| Snapshot | ||
| Sector | Financial Data & Stock Exchanges | -- |
| Last price | 276.01 | 405.32 |
| Change today | +1.79% | +0.30% |
| 1-year return | +10.0% | -14.9% |
| Market cap | $99.25B | $119.49B |
| 52-week range | 217.29 – 318.32 | 358.47 – 518.76 |
| Valuation | ||
| P/E (TTM) | 23.41 | 24.67 |
| P/E percentile, own 5-yr range | 12th | 5th |
| P/B | 3.74 | 3.79 |
| Dividend yield | 4.08% | 0.95% |
| Profitability & growth | ||
| EPS (TTM) | 11.16 | 14.66 |
| Net profit (TTM) | $4.01B | $4.32B |
| Revenue (TTM) | $6.77B | $16.12B |
| Revenue growth (YoY) | +0.8% | +10.4% |
| Gross margin | 86.2% | 70.9% |
| Operating margin | 65.1% | 41.6% |
| Net margin | 63.0% | 30.5% |
| Free cash flow (TTM) | $4.21B | $5.57B |
| Ownership & sentiment | ||
| Institutional ownership | 92.0% | 89.8% |
| Insider activity (12mo) | 18 buy / 4 sell | 5 buy / 2 sell |
| Short interest (% of float) | 1.6% | 2.4% |
| Analyst consensus | 40% buy / 40% hold / 20% sell (10) | 100% buy (17) |
| Analyst price target | $279 (+1%) | $523 (+29%) |
| StockVane view | ||
| StockVane Quant Rating | C (38) | E (10) |
| Company | ||
| Employees | 3,875 | 44,500 |
| Founded | 1898 | 1917 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.